UP reports first case of JN.1 strain

Published On 2024-01-10 12:22 GMT   |   Update On 2024-01-10 12:22 GMT

Uttar Pradesh on Monday reported its first case of the JN.1 strain of Covid. The case involved a 35-year-old doctor affiliated with Sir Ganga Ram Hospital in Delhi, who tested positive on January 1 after visiting her relatives in Vaishali. Since she was in the National Capital Region (NCR) city at the time of receiving her results, Delhi cross-notified the case. Following a genome testing confirming the presence of the new strain, the health directorate in Lucknow received information from Delhi and alerted health officials in Ghaziabad. Subsequently, two relatives the doctor had visited in Vaishali were tested, and they tested negative for Covid on Tuesday. The city's last known case of Covid was a 34-year-old woman on January 2, and currently, there are three active cases in the city.

For more news & updates, check out the link given below:

https://medicaldialogues.in/

Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News